Skeletal Muscle Relaxant Use in the United States: Data from the Third National Health and Nutrition Examination Survey (NHANES III)

Spine

Volumn 29, Issue 8, 2004, Pages 892-896

  Dillon, Charles ^a   Paulose Ram, Ryne ^a   Hirsch, Rosemarie ^a   Gu, Qiuping ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b Orkand Corporation   (United States)

Author keywords

Back pain; Drug utilization; Muscle relaxant; NHANES; Prevalence; Quinine sulfate; Survey

Indexed keywords

BACLOFEN; CARISOPRODOL; CHLORZOXAZONE; CYCLOBENZAPRINE; DANTROLENE; DIAZEPAM; GENERIC DRUG; METAXALONE; METHOCARBAMOL; MUSCLE RELAXANT AGENT; ORPHENADRINE; QUININE SULFATE;

ADOLESCENT; ADULT; AGED; BACKACHE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; DISABILITY; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; MALE; MEDICAL EXAMINATION; MUSCULOSKELETAL DISEASE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; REVIEW; SAMPLING; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACK PAIN; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; NEUROMUSCULAR AGENTS; NUTRITION SURVEYS; QUESTIONNAIRES; TIME FACTORS; UNITED STATES;

EID: 1842682783     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-200404150-00014     Document Type: Review

References (23)

1. Waldman HJ. Centrally acting skeletal muscle relaxants and associated drugs. J Pain Symptom Manage. 1994;7:434-441.
2. van Tulder MW, Koes BW, Bouter LM. Conservative treatment of acute and chronic nonspecific low back pain: a systematic review of randomized controlled trials of the most common interventions. Spine. 1997;22:2128-2156.
3. Villani P, Mugnier B, Bouvenot G. Muscle cramps: reevaluation of the effectiveness of quinine salts. Presse Med. 1999;28:1309-1312.
4. Abrahm JL. Advances in pain management for older adult patients. Clin Geriatr Med. 2000;16:269-311.
5. Amadio P Jr, Cummings DM, Amadio P. Nonsteroidal anti-inflammatory drugs: tailoring therapy to achieve results and avoid toxicity. Postgrad Med. 1993;93:73-97.
6. American Society of Health-System Pharmacists. Therapeutic position statement on the safe use of nonprescription analgesics. Am J Health Syst Pharm. 1999;56:1126-1131.
7. van Tulder M, Koes B. Low back pain and sciatica: acute. Clin Evid. 2002;7:1018-1031.
8. Dreiser RL, Maheu E, Ghozlan R, et al. An epidemiological study of diagnostic and therapeutic strategies in office practice patients with subacute or chronic pain in the thoracic or low back: comparison of practices in primary care and Rheumatology settings. Rev Rhum Engl Ed. 1997;64:26-34.
9. Bigos S, Bowyer O, Braen G, et al. Acute Low Back Problems in Adults: Clinical Practice Guideline no. 14 [AHCPR Publication no. 95-0642]. Rockville, MD: Agency for Health Care Policy and Research, 1994.
10. Pitkala KH, Strandberg TE, Tilvis RS. Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. Arch Intern Med. 2002;162:1707-1712.
11. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994: Vital Health Statistics. Bethesda, MD: National Center for Health Statistics, 1994.
12. Denniston PL Jr, Epner JA, eds. Physicians GenRx: The Official Drug Reference. Smithtown, NY: Data Pharmaceutica Inc., 1993.
13. Pope MH, Goh KL, Magnusson ML. Spine ergonomics. Annu Rev Biomed Eng. 2002;4:49-68.
14. SAS Institute Inc. SAS Procedure Guide, version 6, 3rd edition. Cary, NC: SAS Institute, 1990.
15. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, release 7.0. Research Triangle Park, NC: Research Triangle Institute, 1996.
16. Cherkin DC, Wheeler KJ, Barlow W, Deyo RA. Medication use for low back pain in primary care. Spine. 1998;23:607-614.
17. Cramer GW, Galer BS, Mendelson MA, et al. A drug use evaluation of selected opioid and nonopioid analgesics in the nursing facility setting. J Am Geriatr Soc. 2000;48:398-404.
18. Harkins SW. Geriatric pain: Pain perceptions in the old. Clin Geriatr Med. 1996;12:435-459.
19. Paulose Ram R, Hirsch R, Dillon C, et al. Prescription and non-prescription analgesic use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf. 2003;12:315-326.
20. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med. 1997;157:1531-1536.
21. Browning R, Jackson JL, O'Malley PG. Cyclobenzaprine and back pain: a meta-analysis. Arch Intern Med. 2001;161:1613-1620.
22. Arbus L, Fajadet B, Aubert D, et al. Activity of tetrazepam (myolastan) in low back pain: a double-blind trial vs. placebo. Clin Trials J. 1990;27:258-267.
23. Deyo RA. Drug therapy for back pain: which drugs help which patients? Spine. 1996;21:2840-2849.